The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125990561 12599056 1 I 20160718 20160727 20160727 EXP US-STRIDES ARCOLAB LIMITED-2016SP010143 STRIDES GARLO K, DRESSEL D, SAVIC M, VELLA J.. SUCCESSFUL ECULIZUMAB TREATMENT OF RECURRENT POSTPARTUM ATYPICAL HEMOLYTIC UREMIC SYNDROME AFTER KIDNEY TRANSPLANTATION. CLIN-NEPHROL-CASE-STUD. 2015;2015(1):1-6 0.00 Y 0.00000 20160727 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125990561 12599056 1 PS Hydralazine HCL HYDRALAZINE HYDROCHLORIDE 1 UNK 200770
125990561 12599056 2 SS TACROLIMUS. TACROLIMUS 1 UNK 0
125990561 12599056 3 C PREDNISOLONE. PREDNISOLONE 1 UNK 0
125990561 12599056 4 C PREDNISOLONE. PREDNISOLONE 1 5 MG,DAILY 0 5 MG
125990561 12599056 5 C MYCOPHENOLATE MOFETIL. MYCOPHENOLATE MOFETIL 1 UNK 0
125990561 12599056 6 C MYCOPHENOLATE MOFETIL. MYCOPHENOLATE MOFETIL 1 360 MG, BID 0 360 MG
125990561 12599056 7 C BELATACEPT BELATACEPT 1 450 MG MONTHLY 0 450 MG
125990561 12599056 8 C NEISSERIA MENINGITIDIS. NEISSERIA MENINGITIDIS 1 UNK 0
125990561 12599056 9 C INFLUENZA VACCINE INFLUENZA VIRUS VACCINE 1 UNK 0
125990561 12599056 10 C TETANUS AND DIPHTHERIA TOXOIDS ADSORBED CLOSTRIDIUM TETANICLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)CORYNEBACTERIUM DIPHTHERIAECORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) 1 UNK 0
125990561 12599056 11 C CIPROFLOXACIN. CIPROFLOXACIN 1 500 MG,DAILY 0 500 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125990561 12599056 1 Hypertension
125990561 12599056 2 Immunosuppression
125990561 12599056 3 Immunosuppression
125990561 12599056 5 Immunosuppression
125990561 12599056 7 Immunosuppression
125990561 12599056 8 Immunisation
125990561 12599056 9 Immunisation
125990561 12599056 10 Immunisation
125990561 12599056 11 Antibiotic prophylaxis

Outcome of event

Event ID CASEID OUTC COD
125990561 12599056 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125990561 12599056 Acute kidney injury
125990561 12599056 Haemolytic anaemia
125990561 12599056 Haemolytic uraemic syndrome
125990561 12599056 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found